Bispecific T cell engagers (BiTEs) are immunostimulatory bispecific antibodies, consisting of an anti-CD3ε scFv fused to a tumor-targeted antibody via a flexible linker that primarily activates T cells to kill tumor cells. This evidence concerns the gene CD3E and neoplasm.